Isofol Medical AB (OSTO:ISOFOL) Interest Income : kr4.54 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Isofol Medical AB Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Isofol Medical AB's interest income for the three months ended in Mar. 2024 was kr0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in Mar. 2024 was kr4.54 Mil.

Isofol Medical AB Interest Income Historical Data

The historical data trend for Isofol Medical AB's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Interest Income Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Income

Get a 7-Day Free Trial

0.01

0.15

4.57

Isofol Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Income	Get a 7-Day Free Trial															-	2.04	1.28	1.21	-

Isofol Medical AB Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.54 Mil.

Isofol Medical AB (OSTO:ISOFOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (OSTO:ISOFOL) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

5IU:Germany

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (OSTO:ISOFOL) Headlines

No Headlines